During the upscaling process, Polyrizon and its manufacturing partner successfully transitioned from small-batch laboratory production to a larger-scale, controlled manufacturing run designed to ...

At GIJC25, Peruvian investigative journalist Fabiola Torres showed reporters how to uncover the systems behind pharma ...

Union Minister Piyush Goyal met with Indian pharmaceutical stakeholders to boost industry growth and refine regulations.

In its third-quarter filing, Lilly said its share of the GLP-1 drug market hit 58% in the third quarter. But that's not all.

Beyond epinephrine, the same powder-based platform underlies early-stage pipeline programs in nausea and vomiting induced by chemotherapy, reinforcing that this is not a single-product story but a ...

Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, becoming the first publicly ...

Lilly becomes the first pharmaceutical company to hit that threshold, joining a select club of mostly tech companies.

HHS Secretary Robert F. Kennedy Jr. takes near-daily calls with President Donald Trump, with aides sitting on the floor and ...

Welcome to the Jefferies London Healthcare Conference. My name is Dennis Ding, biotech and spec pharma analyst here at Jefferies. And I have the wonderful pleasure of having Richard Francis here, CEO ...

Even $149 a month, the advertised price for a starting dose of a still-in-development GLP-1 pill on TrumpRx, will be too big ...

New investor AXA IM Alts joins upsized Series B round to support clinical advancement and expand global health impact of ninerafaxstat, a novel ...